The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG – functional fibrinogen method: preliminary results
Restricted accessResearch articleFirst published online November, 2011
The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG – functional fibrinogen method: preliminary results
When cardiopulmonary bypass (CPB) is used, the blood comes into contact with foreign surfaces. To diminish this impact, various types of biocompatibly coated surfaces have been developed. The study assessed the effects of heparin-coated CPB systems on the level and function of fibrinogen as measured by thromboelastography (TEG), as compared with non-coated systems. No statistically significant differences between both groups were revealed by comparing paired data. In our study, heparin-coated CPB circuits had no significant effect on either fibrinogen level or its function.
DeptulaJGlogowskiKMerriganK. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery. J Extra Corpor Technol2006Mar; 38(1): 22–26.
2.
KohSCChewCYViegasOAChooMRatnamSS. Influence of circulating D-dimer levels on assays of fibrinogen. Ann Acad Med Singapore1994Nov; 23(6): 856–860.
3.
CarrollRCCraftRMChavezJSniderCCKirbyRCohenE. Measurement of functional fibrinogen levels using the Thrombelastograph. J Clinic Anesth2008; 20: 186–190.
4.
PappalardoFDella VallePCrescenziG. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg2006Mar; 81(3): 886–891.
5.
BorowiecJThelinSBaggeLNilssonLVengePHanssonHE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg1992; 104: 642–647.
6.
FosseEMoenOJohnsonE. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg1994; 58: 472–477.
7.
JameelSColahSKleinA. Recent advances in cardiopulmonary bypass techniques. CEACCP2010; 10(1): 20–23.
8.
WagnerWRJohnsonPCThompsonKAMarroneGC. Heparin-coated cardiopulmonary bypass circuits: hemostatic alteration and postoperative blood loss. Ann Thorac Surg1994; 58: 734–740.
9.
GormanRCZiatsNPRaoAK. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg1996; 111: 1–12.
10.
RanucciMBalduiniADittaABoncilliABrozziS. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg2009; 87: 1311–1319.
11.
MangoushOPurkayasthaSHaj-YahiaS. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg2007; 31: 1058–1069.
12.
NakahiraASasakiYHiraiH. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery.Thorac Cardiovasc Surg2011May; 141(5): 1289–1297.
